by admin_63069 | Apr 21, 2025 | News You Can Use
AI can help patients decide whether active surveillance is right for them.
by admin_63069 | Apr 14, 2025 | News You Can Use
Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by conventional imaging.
by admin_63069 | Apr 7, 2025 | News You Can Use
Virginia Mason Franciscan Health taps Seattle’s sports love by helping eligible patients learn about prostate-cancer screening at sporting events.
by admin_63069 | Mar 31, 2025 | News You Can Use
Interpreting results in the context of evolving therapies, patient choice, and ongoing trials.
by admin_63069 | Mar 24, 2025 | News You Can Use
This study was specifically about the barriers and facilitators to first-line treatment intensification in metastatic castration-sensitive prostate cancer.
by admin_63069 | Mar 17, 2025 | News You Can Use
Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower death risk with Talzenna plus Xtandi.
